|
|
Volumn 122, Issue 6, 2008, Pages 1406-1408
|
|
Statin use in children in the United States
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
FLUINDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MEVINOLIN;
PRAVASTATIN;
ROSUVASTATIN;
SIMVASTATIN;
ADOLESCENT;
AGE;
CHILD;
FEMALE;
GENDER;
HEALTH INSURANCE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MEDICAID;
PRESCRIPTION;
PRIORITY JOURNAL;
UNITED STATES;
CLINICAL PRACTICE;
COST BENEFIT ANALYSIS;
DRUG UTILIZATION;
ECONOMICS;
HOSPITALIZATION;
HYPERLIPIDEMIA;
MEDICAL SOCIETY;
NOTE;
PEDIATRICS;
PRACTICE GUIDELINE;
RISK ASSESSMENT;
STANDARD;
TREATMENT OUTCOME;
ADOLESCENT;
AGE FACTORS;
CHILD;
COST-BENEFIT ANALYSIS;
DRUG UTILIZATION;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPIDEMIAS;
MALE;
PEDIATRICS;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES AS TOPIC;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SOCIETIES, MEDICAL;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 58249094732
PISSN: 00314005
EISSN: 10984275
Source Type: Journal
DOI: 10.1542/peds.2008-2231 Document Type: Letter |
|
Times cited : (7)
|
|
References (3)
|
